Mohamed Elshenawy, Chief Technology Officer of Hims & Hers Health, Inc. (NYSE:HIMS), filed a Form 4 on November 17, 2026, disclosing transactions in Class A Common Stock and restricted stock units dated November 13, 2026.

Key Highlights

  • RSU settlement: Elshenawy acquired 188,286 shares of Class A Common Stock via RSU vesting (transaction code M) on November 13, 2026.
  • Tax withholding: 95,798 shares were withheld by the issuer at $19.73 per share to cover tax obligations connected to the RSU settlement (transaction code F).
  • Direct ownership after transactions: Elshenawy directly held 278,044 shares of Class A Common Stock following the reported transactions.
  • Three RSU grants involved: Vesting drew from three separate RSU awards: 64,772 units, 23,514 units, and 100,000 units, each converting to Class A Common Stock at $0 exercise price.
  • Remaining derivative holdings: Following the transactions, Elshenawy held 647,712, 305,681, and 1,000,000 RSUs remaining under the three respective grants.
  • New grant disclosed: The 100,000-unit RSU award is described as a new grant, vesting in substantially equal quarterly installments over 3 years, with the first vesting date to be the first Company Quarterly Vesting Date following the grant date.

Elshenawy RSU Transactions at Hims & Hers Health on November 13, 2026

According to the Form 4 filing, Mohamed Elshenawy, identified as Chief Technology Officer of Hims & Hers Health, Inc., reported three RSU settlements on November 13, 2026. The vesting events converted a combined 188,286 RSUs into an equal number of Class A Common Stock shares. Each RSU represented "a contingent right to receive one share of Class A Common Stock for each RSU," according to the filing's explanation of responses.

The filing disclosed that 95,798 of those shares were subsequently withheld by the issuer at a price of $19.73 per share to satisfy tax withholding obligations arising from the vesting. After the acquisition and the withholding, Elshenawy's direct beneficial ownership of Class A Common Stock stood at 278,044 shares, the filing stated.

Two of the three RSU grants involved are subject to service-based vesting over a 4-year period. The first grant of 64,772 units had 25% vest on June 15, 2026, with the remaining 75% vesting in substantially equal quarterly installments thereafter. The second grant of 23,514 units vests in substantially equal quarterly installments beginning June 15, 2026. The third grant, covering 100,000 units, is described in the filing as a newly granted award vesting over 3 years in substantially equal quarterly installments, with the first vesting date to be the first applicable Company Quarterly Vesting Date after the grant date. The filing was signed by Kimberly Mather as Attorney-in-Fact for Mohamed Elshenawy on November 17, 2026.

What Was Disclosed

The filing reported RSU vesting resulting in 188,286 shares acquired, 95,798 shares withheld for taxes at $19.73, and a resulting direct holding of 278,044 Class A Common Stock shares, along with remaining RSU balances across three grants totaling over 1.9 million units.